EUVIMEDObjevte EUVIMED
Video/Audio

Differentiation of Human Induced Pluripotent Stem Cells to Brain Microvascular Endothelial Cell-Like Cells with a Mature Immune Phenotype

Kinya Matsuo, Britta Engelhardt, Hideaki Nishihara

Journal of Visualized Experiments · 2023

DOI: 10.3791/65134 ↗

At a glance

Video/Audio in Journal of Visualized Experiments, 2023. Written by Kinya Matsuo and 2 co-authors. Institution: Graduate School of Medicine, Yamaguchi University. Major MEDLINE topics: Endothelial Cells, Induced Pluripotent Stem Cells. Cited 12 times so far (Crossref); 32 references.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Blood-brain barrier (BBB) dysfunction is a pathological hallmark of many neurodegenerative and neuroinflammatory diseases affecting the central nervous system (CNS). Due to the limited access to disease-related BBB samples, it is still not well understood whether BBB malfunction is causative for disease development or rather a consequence of the neuroinflammatory or neurodegenerative process. Human induced pluripotent stem cells (hiPSCs) therefore provide a novel opportunity to establish in vitro BBB models from healthy donors and patients, and thus to study disease-specific BBB characteristics from individual patients. Several differentiation protocols have been established for deriving brain microvascular endothelial cell (BMEC)-like cells from hiPSCs. Consideration of the specific research question is mandatory for the correct choice of the respective BMEC-differentiation protocol. Here, we describe the extended endothelial cell culture method (EECM), which is optimized to differentiate hiPSCs into BMEC-like cells with a mature immune phenotype, allowing the study of immune cell-BBB interactions. In this protocol, hiPSCs are first differentiated into endothelial progenitor cells (EPCs) by activating Wnt/β-catenin signaling. The resulting culture, which contains smooth muscle-like cells (SMLCs), is then sequentially passaged to increase the purity of endothelial cells (ECs) and to induce BBB-specific properties. Co-culture of EECM-BMECs with these SMLCs or conditioned medium from SMLCs allows for the reproducible, constitutive, and cytokine-regulated expression of EC adhesion molecules. Importantly, EECM-BMEC-like cells establish barrier properties comparable to primary human BMECs, and due to their expression of all EC adhesion molecules, EECM-BMEC-like cells are different from other hiPSC-derived in vitro BBB models. EECM-BMEC-like cells are thus the model of choice for investigating the potential impact of disease processes at the level of the BBB, with an impact on immune cell interaction in a personalized fashion.

Subjects

MeSH terms (MEDLINE)

Endothelial CellsInduced Pluripotent Stem CellsHumansCells, CulturedBrainBlood-Brain BarrierCell DifferentiationPhenotype

Authors and institutions

  • Graduate School of Medicine, Yamaguchi University.
  • Theodor Kocher Institute, University of Bern.
  • Department of Neurotherapeutics, Yamaguchi University of Medicine; hidehara@yamaguchi-u.ac.jp.

Cite

APA

Matsuo, K., Engelhardt, B., & Nishihara, H. (2023). Differentiation of Human Induced Pluripotent Stem Cells to Brain Microvascular Endothelial Cell-Like Cells with a Mature Immune Phenotype. Journal of Visualized Experiments. https://doi.org/10.3791/65134

Vancouver

Matsuo K, Engelhardt B, Nishihara H. Differentiation of Human Induced Pluripotent Stem Cells to Brain Microvascular Endothelial Cell-Like Cells with a Mature Immune Phenotype. Journal of Visualized Experiments. 2023. doi:10.3791/65134

BibTeX
@article{Matsuo2023,
  author = {Matsuo, Kinya and Engelhardt, Britta and Nishihara, Hideaki},
  title = {Differentiation of Human Induced Pluripotent Stem Cells to Brain Microvascular Endothelial Cell-Like Cells with a Mature Immune Phenotype},
  journal = {Journal of Visualized Experiments},
  year = {2023},
  doi = {10.3791/65134}
}
Start for free →